Building on the success of the first edition, Asia Biotech Invest will return to Hong Kong from 3-5 June 2014. Join us again at Hong Kong’s one and only life science investment showcase and hear even more biotech and medtech companies present their pipelines, have insightful discussions with industry leaders, meet with life science investors and make deals!
Research has shown that there is a growing appetite for life science investment in Asia. Asia Biotech Invest provides access to Asia’s large investor community and a range of funding sources, including private equity, venture capital, institutional capital and family offices. Take advantage of this trends and let us connect you with the capital you need to move your biotech innovations forward.
Thu, 19/02/2015 - 18:04
Read how managers seeking to distribute in Europe can appoint a third party AIFM (or ManCo), and the fund distribution benefits this can bring, both for new fund launches and redomiciled funds... »
Tue, 10/02/2015 - 13:49
Global gross domestic product (GDP) growth should accelerate somewhat in 2015 and 2016 from the pace of the last three years because of much lower oil prices, the avoidance of special drags on the world economy, and continuing easy monetary policies from global central banks, according to BNY Mellon Chief Economist Richard Hoey. Hoey (pictured) made the comments in his February outlook. ... »
Fri, 30/01/2015 - 10:12
55% of private equity firms surveyed by Preqin at the end of 2014 stated they would deploy greater levels of capital in 2015, although 39% suggested it is more difficult to find attractive investments. Preqin’s Christopher Elvin comments: ... »
Wed, 14/01/2015 - 13:22
Over half of infrastructure funds that closed in 2014 exceeded their fundraising target, up from 37% of funds in 2013. Andrew Moylan, Preqin’s Head of Real Assets Products, takes a look at infrastructure fundraising over the last 12 months: ... »
Tue, 20/01/2015 - 12:26
977 private equity funds held a final close throughout the year raising a total of USD486bn, higher than any annual amount between 2009 and 2012, and on track to match the 2013 total. Preqin’s Christopher Elvin (pictured) reviews a year of private equity fundraising: ... »